Access To Medicine Foundation
  • Who we are
  • What we do
  • Impact
  • Insights & resources
  • News & events
  • Donate
Donate

Who we are

An independent non-profit organisation accelerating progress toward global health equity.

  • About us
  • How we drive change
  • Our strategy 2022 - 2026
  • Governance
  • Team
  • Funders
  • Annual reports

What we do

We catalyse progress toward equitable access to essential medicines in low- and middle-income countries through our work across diverse research areas.

  • R&D-based pharma companies
  • Medical gas companies
  • Generic medicine manufacturers
  • Diagnostics companies
  • Vaccine manufacturers
  • Antimicrobial resistance
  • Diabetes care

Impact

Discover how our work drives real-world progress on access to medicine.

  • Our achievements
  • Voices of our community
  • How we drive change
  • Partner with us

Insights & resources

Discover our evidence-based research, insights and other changemaking tools.

  • Research hub
  • Company profiles & report cards
  • Access insights
  • The Health Equity podcast
  • Health Equity through Her Lens

News & events

Stay informed on our latest events, collaborations, engagements, and Foundation news.

  • News
  • Events & engagements
  • In the media

Follow us

Often searched

Index ranking

Vacancies

10 year analysis

Follow us

  • About us
  • How we drive change
  • Our strategy 2022 - 2026
  • Governance
  • Team
  • Funders
  • Annual reports
  • R&D-based pharma companies
  • Medical gas companies
  • Generic medicine manufacturers
  • Diagnostics companies
  • Vaccine manufacturers
  • Antimicrobial resistance
  • Diabetes care
  • Our achievements
  • Voices of our community
  • How we drive change
  • Partner with us
  • Research hub
  • Company profiles & report cards
  • Access insights
  • The Health Equity podcast
  • Health Equity through Her Lens
  • News
  • Events & engagements
  • In the media

FT Global Pharmaceutical and Biotechnology Conference

On Monday 8 November 2021, Margo Warren will join the Financial Times' virtual Global Pharmaceutical and Biotechnology Conference to discuss pharma pipelines.

Date

08 November 2021

About the event
FT Live is the global conferences and events division of the Financial Times Group. This event, hosted virtually, will welcome over 2,000 attendees, feature over 50 speakers, and include more than 1,000 companies from around the globe. FT Live aims connect global executive audiences to each other while providing the latest in knowledge and opinion.

Session: "Pricing and market access trends"
Margo Warren, Head of Policy for the Foundation, will join the "Pricing and market access trends" session, hosted by Carole Longson, Life Sciences Adviser at NICE, to discuss topics including: 

  • What are the prospects for health policy and regulatory reforms around market access?

  • What could be the legacy of the pandemic in terms of standards and processes to support product approval?

  • How could the balance of power between pharma, payers, patients and other stakeholders shift in the next few years?

Please click here for a detailed agenda and more information. 

Access to Medicine Foundation

Subscribe to our newsletter

Vacancies FAQs Contact us

Follow us

Access to Medicine Foundation is funded by

Terms & conditions Privacy & cookie policy Disclaimer

Copyright 2004 - 2026 Access to Medicine Foundation - All Rights Reserved